DuPont bioscience chief exits on eve of spinoff to head drug development consulting company

Delaware Business Now

May 31, 2019

Feehery Certara announced it has appointed Dr. Feehery as its new Chief Executive Officer effective June 3. Feehery joins Certara from DuPont, where he has served since 2013 as pre…